Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Tim Watkins currently holds 238,334 shares of Contineum Therapeutics, Inc. (CTNM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Tim Watkins has been a net seller of CTNM stock. They have purchased $0 and sold $271.4K worth of shares.
Tim Watkins's most recent insider trade was on Jun 30, 2026, when they sold 10,833 shares at $0.00 per share.
Tim Watkins serves as Executive at Contineum Therapeutics, Inc. (CTNM). They have executed 8 insider transactions totaling $271.4K over their tenure at the company.
Tim Watkins holds the position of Executive at Contineum Therapeutics, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Tim Watkins has shown a selling trading pattern, with $0 in total purchases and $271.4K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Tim Watkins was on Jun 30, 2026, when they sold $173.6K worth of CTNM shares. This transaction involved 10,833 shares at $16.02 per share.
Tim Watkins currently owns 238,334 shares of Contineum Therapeutics, Inc. (CTNM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Tim Watkins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Tim Watkins has 8 Form 4 filings on record as an insider at Contineum Therapeutics, Inc..
Set alerts for Tim Watkins and 40,000+ other insiders.